Ardent Health (ARDT) Stock: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$10.25
-0.09 (-0.87%)
▼
5d:
-2.19%
30d:
-6.31%
90d:
-4.74%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARDT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ARDT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.90
Based on 9.7% avg growth
INTRINSIC VALUE TODAY
$9.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $10.25, which is considered oversold relative to its 30-day fair value range of $10.53 to $11.06. The stock's valuation (Forward PE: 8.2) is in line with its historical norms (7.5). At these levels, the market is pricing in 2.8% annual earnings growth.
Technical Outlook: Technically, ARDT is in a uptrend. The price is currently testing key support at $10.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.67 (+23.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDT is in a uptrend. The price is currently testing key support at $10.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.67 (+23.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.53 -
$11.06
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.6% below Wall St target ($12.67)
- BULLISH: Expecting earnings turnaround to 2.8% growth with -1.4% revenue growth
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$10.53 -
$11.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.08
Resistance Level
$11.03
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.17
Wall Street Target
$12.67
(+23.6%)
Revenue Growth (YoY)
-1.4%
Earnings Growth (YoY)
-77.1%
Profit Margin
1.2%
Valuation Premium vs History
+2.8% premium
PE vs Historical
8.2 vs 7.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.8%
(market-implied from PE analysis)
1-Year Target
$10.54
(+3%)
2-Year Target
$10.83
(+6%)
3-Year Target
$11.14
(+9%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$10.23
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 15.4%)
$39.35
(+284%)
Base:
(SPY PE: 8.2, Growth: 15.4%)
$15.75
(+54%)
Bear:
(PE: 6.9, Growth: 15.4%)
$13.39
(+31%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 19.51 | Current EPS (TTM): $0.53
Bull Case
$22.75
(+122%)
Analyst growth 100.0%, PE expands to 21.5
Base Case
$20.68
(+102%)
Market implied 100.0%, PE stable at 19.5
Bear Case
$7.03
(-31%)
Severe decline -20.0%, PE contracts to 16.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 6:42 AM ET
Data refreshes hourly during market hours. Next update: 7:42 AM
Data refreshes hourly during market hours. Next update: 7:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 46 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 53 HOLD |
